Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > New base $2

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Jan 06, 2022 11:33pm

197 Views

Post# 34291689

RE:RE:RE:RE:RE:RE:RE:RE:RE:New base $2

Bio Tresiba the long acting insulin went down from 14U to 8U, that's significant, no other peers have come close. You haven't been this concerned about the SP going up since last year, must mean there is potential for one hell of a run.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism